100
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Adriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization

, , , &
Pages 535-539 | Published online: 09 Oct 2022

References

  • AvgoustakisKBeletsiAPanagiZ2003Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticlesInt J Pharm2591152712787641
  • BeletsiALeondiadisLKlepetsanisP1999Effect of preparative variables on the properties of PLGA-mPEG copolymers related to their applications in controlled drug deliveryInt J Pharm1821879710341308
  • BeletsiAPanagiZAvgoustakisK2005Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymersInt J Pharm2982334115936907
  • BirnbaumDTBrannon-PeppasL2004Microparticle drug delivery systemsBrownDMDrug delivery systems in cancer therapyHumana Press11735
  • EatockMMSchätzlainAKayeSB2000Tumor vasculature as a target for anticancer therapyCancer Treat Rev2619120410814561
  • GrefRMinamitakeYPeracchiaMT1994Biodegradable long circulating polymeric nanosphersScience2631600308128245
  • JeongYNahJWLeeHC1999Adriamycin release from flower-type polymeric micells based on star-block copolymer composed of poly (γ- Benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic partInt J Pharm188495810528082
  • KwonGSNaitoMYokoyamaM1995Physical entrapment of adriamycin in AB block copolymer micellePharm Res1219257784332
  • LiYPPeiYYZhangXY2001PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsJ Control Release712031111274752
  • MitraSGaurUGhoshPC2001Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosane nanoparticles as carrierJ Control Release743172311489513
  • NaKLeeESBaeYH2003Adriamycin loaded pulluan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependant cell interaction, internalization and cytotoxicityJ Control Release8731312618018
  • OriveGHernándezRMGascAR2005Micro and nano drug delivery systems in cancer therapyCancer Ther31318
  • PanyamJLabhasetwarV2003Biodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Del Rev5532947
  • PeppasLBBlanchetteJO2004Nanoparticle and targeted systems for cancer therapyAdv Drug Del Rev56164959
  • ReynoldsARMoghimiSMHodivala-DilkK2003Nanoparticle-mediated gene delivery to tumor vasculatureTrends Mol Med92412524203
  • ShikataFTokumitsoHIchikavaH2002In vitro cellular accumulation of gadolinium incorporated into chitosane nanoparticles designed for neutron-capture therapy of cancerEur J Pharm Biopharm53576311777753
  • SledgeGMillerK2003Exploiting the hallmarks of cancer: the future conquest of breast cancerEur J Cancer3916687512888360
  • StubbsMMcSheelyPMJGriffithsJR2000Causes and consequence of tumor acidity and implications for treatmentMol Med Today6151910637570
  • TannockIFRotinD1989Acid pH in tumors and its potential for therapeutic exploitationCancer Res494373842545340
  • TeicherBA2000Molecular targets and cancer therapeutics: discovery, development and clinical validationDrug Resist Updat3677311498368
  • YooHSParkTG2000In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesPolymer Prepr419923